Reevaluation of Conventional Pituitary Irradiation in the Therapy of Acromegaly

被引：12

作者：

Jaffe C.A. ^{[1
,2
]}

机构：

[1] Department of Internal Medicine, Univ. of Michigan Medical Center, Ann Arbor Vet. Aff. Medical Center

[2] 3920 Taubman Center, Ann Arbor, MI 48109-0354

来源：

Pituitary | 1999年 / 2卷 / 1期

关键词：

Adenoma; Anterior pituitary; Growth hormone; Insulin-like growth factor I; Neoplasia;

D O I：

10.1023/A:1009969921497

中图分类号：

学科分类号：

摘要：

External beam pituitary irradiation has been frequently used in the treatment of growth hormone (GH) secreting pituitary adenomas. Many studies have demonstrated that serum GH declines rapidly and reliably following treatment and early "cure" rates, based on a basal serum GH below 10 μg/L were as high as 80%. The definition of "cure" has become more stringent over time and retrospective studies have indicated that GH must be below 2.5 μg/L for acromegalics to achieve mortality rates comparable to a normal population. Only 20% of irradiated patients will achieve this goal by 10 yr. Even fewer will achieve a normal serum insulin-like growth factor I (IGF-I) levels. Although pituitary irradiation still has a role in the control of tumor size, its importance as a treatment for normalizing serum GH is being reevaluated.

引用

页码：55 / 62

页数：7

共 64 条

[11]

Chang-DeMoranville B.M., Jackson I.M.D., Diagnosis and endocrine testing in acromegaly, Endocrinol Metab Clin North Am, 21, pp. 649-668, (1992)

[12]

Chapman I.M., Hartman M., Straume M., Johnson M.L., Veldhuis J.D., Thorner M.O., Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women, J Clin Endocrinol Metab, 78, pp. 1312-1319, (1994)

[13]

Barkan A.L., Beitins I.Z., Kelch R.P., Plasma insulin-like growth factor-I/somatomedin-c in acromegaly: Correlation with the degree of growth hormone hypersecretion, J Clin Endocrinol Metab, 67, pp. 69-73, (1988)

[14]

Daughaday W.H., Starkey R.H., Saltman S., Gavin III J.R., Mills-Dunlop B., Health-Monnig E., Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH, J Clin Endocrinol Metab, 65, pp. 617-623, (1987)

[15]

Brockmeier S.J., Buchfelder M., Adams E.F., Schott W., Fahlbusch R., Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery, Horm Metabol Res, 24, pp. 392-400, (1992)

[16]

Barkan A.L., Halasz I., Dornfeld K.J., Jaffe C.A., DeMott Friberg R., Chandler W.F., Et al., Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly, J Clin Endocrinol Metab, 82, pp. 3187-3191, (1997)

[17]

Spagnoli A., Rosenfeld R.G., The mechanisms by which growth hormone brings about growth, Endocrinol Metab Clin North Am, 25, pp. 615-631, (1996)

[18]

Eastman T.C., Gorden P., Glatstein E., Roth J., Radiation therapy of acromegaly, Endocrinol Metab Clin North Am, 21, pp. 693-712, (1992)

[19]

Halberg F.E., Sheline G.E., Radiotherapy of pituitary tumors, Endocrinol Metab Clin North Am, 16, pp. 667-684, (1987)

[20]

Feek C.M., McLelland J., Seth J., Toft A.D., Irvine W.J., Padfield P.L., Edwards C.R., How effective is external pituitary irradiation for growth hormone-secreting pituitary tumors?, Clin Endocrinol, 20, pp. 401-408, (1984)

← 1 2 3 4 5 6 7 →